Table 3.
Breakdown of ATL patients received with (a) VCAP (Day 1 of each cycle) and VECP (Day 15–17 of each cycle: ※) of mLSG15/-L regimen, (b) CHOP/-L regimen
| Cycle number | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 1※ | 2 | 2※ | 3 | 3※ | 4 | 4※ | |
| (a) | ||||||||
| Number of received patients | 9 | 8 | 8 | 8 | 7 | 6 | 5 | 2 |
| Number of analyzed patients | 9 | 8 | 8 | 8 | 7 | 6 | 5 | 2 |
| Number of missing data | – | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number of taken off therapy | – | 0 | 1 | 1 | 2 | 3 | 4 | 7 |
| Cycle number | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
| (b) | ||||||||
| Number of received patients | 5 | 5 | 3 | 2 | 2 | 0 | 1 | 1 |
| Number of analyzed patients | 5 | 5 | 3 | 2 | 2 | 0 | 1 | 1 |
| Number of missing data | – | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Number of taken off therapy | – | 0 | 2 | 3 | 3 | 3 | 4 | 4 |